Company: BGLC
Filing Date: 2025-08-14
Form Type: NT 10-Q
Source: 0001477932-25-005903
Chunk: 1

Company: BioNexus Gene Lab Corp
Filing Date: 2025-08-14
Form: NT 10-Q
Chunk 1
---
 without unreasonable effort or expense and expects to file on or before the fifth calendar day following the original due date, pursuant to Rule 12b-25(b).

<div align='center'>PART IV: OTHER INFORMATION</div>

| (1) | Name and telephone number of person(s) to contact in regard to this notification |

| Su-Leng Tan Lee |     |        +1 |     |     307 241 6898 |
| Name            |     | Area Code |     | Telephone Number |

| (2) | Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the Registrant was required to file such report(s) been filed? If the answer is no, identify report(s). |
|     | YES ☒   NO ☐                                                                                                                                                                                                                                                                                                                         |

| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? |

| YES ☐   NO ☒                                                                                                                                                                                 |
| If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. |

| 2 |

BioNexus Gene Lab Corp. has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

| Dated: August 14, 2025 | BioNexus Gene Lab Corp. 
 By:                     | /s/ Su-Leng Tan Lee     |
|:-----------------------|:------------------------|:------------------------|
|                        | Name:                   | Su-Leng Tan Lee         |
|                        | Title:                  | Chief Executive Officer |

| 3 |